Biohaven Pharmaceutical Holding Company Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Biohaven Pharmaceutical Holding Company Ltd.
The merger closed in May, so the second quarter earnings report will be the first presentation of the combined company’s performance and outlook.
After a prior failure in treating anxiety, the company believes the glutamate modulator showed signs of efficacy in obsessive-compulsive disorder that are worth pursuing, including at a higher dose.
Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.
Pharma is assessing digital-first launch strategies amid COVID-19 while a resizing of sales forces and the emergence of "digital orchestrators" may also be in store, the co-founder of healthcare solutions provider Indegene tells Scrip.
- Controlled Release
- Drug Delivery
- Large Molecule
- Other Names / Subsidiaries
- Portage Biotech Inc.
- Portage Glasgow Limited (PGL)
- Biohaven Pharmaceuticals, Inc.